These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 9761245

  • 21. Effect of pamidronate on excretion of pyridinium crosslinks of collagen after total hip arthroplasty.
    Wilkinson JM, Jackson B, Eastell R.
    Calcif Tissue Int; 2003 Oct; 73(4):326-31. PubMed ID: 12874697
    [Abstract] [Full Text] [Related]

  • 22. Urinary free deoxypyridinoline levels during childhood.
    Conti A, Ferrero S, Giambona S, Sartorio A.
    J Endocrinol Invest; 1998 May; 21(5):318-22. PubMed ID: 9648054
    [Abstract] [Full Text] [Related]

  • 23. Total and free deoxypyridinoline after acute osteoclast activity inhibition.
    Rubinacci A, Melzi R, Zampino M, Soldarini A, Villa I.
    Clin Chem; 1999 Sep; 45(9):1510-6. PubMed ID: 10471654
    [Abstract] [Full Text] [Related]

  • 24. Evidence that serum NTx (collagen-type I N-telopeptides) can act as an immunochemical marker of bone resorption.
    Clemens JD, Herrick MV, Singer FR, Eyre DR.
    Clin Chem; 1997 Nov; 43(11):2058-63. PubMed ID: 9365389
    [Abstract] [Full Text] [Related]

  • 25. Comparison of analytical performance and biological variability of three bone resorption assays.
    Ju HS, Leung S, Brown B, Stringer MA, Leigh S, Scherrer C, Shepard K, Jenkins D, Knudsen J, Cannon R.
    Clin Chem; 1997 Sep; 43(9):1570-6. PubMed ID: 9299935
    [Abstract] [Full Text] [Related]

  • 26. Comparative evaluation of CLIA and EIA for Quantiferon-TB Gold Plus.
    Brantestig S, Kinnunen A, Almeflo S, Restorp K, Ahlqvist J, Dyrdak R.
    APMIS; 2020 Apr; 128(4):343-349. PubMed ID: 31976577
    [Abstract] [Full Text] [Related]

  • 27. A randomized clinical trial comparing oral alendronate and intravenous pamidronate for the treatment of Paget's disease of bone.
    Walsh JP, Ward LC, Stewart GO, Will RK, Criddle RA, Prince RL, Stuckey BG, Dhaliwal SS, Bhagat CI, Retallack RW, Kent GN, Drury PJ, Vasikaran S, Gutteridge DH.
    Bone; 2004 Apr; 34(4):747-54. PubMed ID: 15050907
    [Abstract] [Full Text] [Related]

  • 28. Bone resorption in multiple myeloma and in monoclonal gammopathy of undetermined significance: quantification by urinary pyridinium cross-links of collagen.
    Pecherstorfer M, Seibel MJ, Woitge HW, Horn E, Schuster J, Neuda J, Sagaster P, Köhn H, Bayer P, Thiébaud D, Ludwig H.
    Blood; 1997 Nov 01; 90(9):3743-50. PubMed ID: 9345061
    [Abstract] [Full Text] [Related]

  • 29. Immunoassay for urinary pyridinoline: the new marker of bone resorption.
    Seyedin SM, Kung VT, Daniloff YN, Hesley RP, Gomez B, Nielsen LA, Rosen HN, Zuk RF.
    J Bone Miner Res; 1993 May 01; 8(5):635-41. PubMed ID: 8511991
    [Abstract] [Full Text] [Related]

  • 30. Urinary deoxypyridinoline excretion for the evaluation of bone turnover in chronic renal failure.
    Coen G, Mantella D, Calabria S, Sardella D, Manni M, Fassino V, D'Anello E, Giustini M, Taggi F.
    Am J Nephrol; 2000 May 01; 20(4):283-90. PubMed ID: 10970981
    [Abstract] [Full Text] [Related]

  • 31. Neridronate preferentially suppresses the urinary excretion of peptide-bound deoxypyridinoline in postmenopausal women.
    Tobias JH, Laversuch CV, Wilson N, Robins SP.
    Calcif Tissue Int; 1996 Nov 01; 59(5):407-9. PubMed ID: 8849410
    [Abstract] [Full Text] [Related]

  • 32. Development of an immunoassay for urinary galactosylhydroxylysine.
    Leigh SD, Ju HS, Lundgard R, Daniloff GY, Liu V.
    J Immunol Methods; 1998 Nov 01; 220(1-2):169-78. PubMed ID: 9839938
    [Abstract] [Full Text] [Related]

  • 33. Urinary free deoxypyridinoline excretion in lactating and non-lactating Arabic women of the United Arab Emirates.
    Miller CJ, Dunn EV, Thomas EJ, Sankarankutty M.
    Ann Clin Biochem; 2003 Jul 01; 40(Pt 4):394-7. PubMed ID: 12880541
    [Abstract] [Full Text] [Related]

  • 34. Comparison of immuno- and HPLC-assays for the measurement of urinary collagen cross-links.
    Calabresi E, Lasagni L, Franceschelli F, de Leonardis V, Becorpi A, Serio M, Brandi ML.
    J Endocrinol Invest; 1994 Sep 01; 17(8):625-9. PubMed ID: 7868800
    [Abstract] [Full Text] [Related]

  • 35. Urinary hydroxypyridinium crosslinks of collagen in population-based screening for overt vertebral osteoporosis: results of a pilot study.
    Seibel MJ, Woitge H, Scheidt-Nave C, Leidig-Bruckner G, Duncan A, Nicol P, Ziegler R, Robins SP.
    J Bone Miner Res; 1994 Sep 01; 9(9):1433-40. PubMed ID: 7817828
    [Abstract] [Full Text] [Related]

  • 36. Short- and long-term effects of ibandronate treatment on bone turnover in Paget disease of bone.
    Woitge HW, Oberwittler H, Heichel S, Grauer A, Ziegler R, Seibel MJ.
    Clin Chem; 2000 May 01; 46(5):684-90. PubMed ID: 10794751
    [Abstract] [Full Text] [Related]

  • 37. A collection method and high-sensitivity enzyme immunoassay for sweat pyridinoline and deoxypyridinoline cross-links.
    Sarno M, Powell H, Tjersland G, Schoendorfer D, Harris H, Adams K, Ogata P, Warnick GR.
    Clin Chem; 1999 Sep 01; 45(9):1501-9. PubMed ID: 10471653
    [Abstract] [Full Text] [Related]

  • 38. Evaluation of new bone resorption markers in a randomized comparison of pamidronate or clodronate for hypercalcemia of malignancy.
    Vinholes J, Guo CY, Purohit OP, Eastell R, Coleman RE.
    J Clin Oncol; 1997 Jan 01; 15(1):131-8. PubMed ID: 8996134
    [Abstract] [Full Text] [Related]

  • 39. Markers of bone resorption--measurement in serum, plasma or urine?
    Huber F, Traber L, Roth HJ, Heckel V, Schmidt-Gayk H.
    Clin Lab; 2003 Jan 01; 49(5-6):203-7. PubMed ID: 15285175
    [Abstract] [Full Text] [Related]

  • 40. Bone turnover in malnourished children.
    Branca F, Robins SP, Ferro-Luzzi A, Golden MH.
    Lancet; 2003 Jan 01; 340(8834-8835):1493-6. PubMed ID: 1361595
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.